ARCHIVES

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

This article is from The Cancer Letter archive.

Vol. 02 No. 40 | October 1, 1976

Download PDF Visit The Full Archive

Related Articles

Agreement Nears On New Guidelines For Center Grants

November 14, 1980

Pollin Prize honors four pioneers in treatment of childhood leukemia.

December 12, 2003

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012